Trevi Therapeutics to Present at Needham & Company’s 17th Annual Healthcare Conference
New Haven, CT, March 21, 2018 – Trevi Therapeutics, Inc. (“Trevi”), a late-stage clinical development company focused on developing Nalbuphine® ER for chronic pruritus (itch), today announced that Jennifer Good, President and Chief Executive Officer, will present at Needham & […]